Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Company announcement

OBN Awards 2018 – Winners Recognised at Industry Leading Event

The OBN Annual Awards celebrates the achievements of the UK life sciences industry.

Read the rest of entry »

Thermo Fisher Scientific brought Science World successfully back to Manchester

Science World, the Fisher Scientific Laboratory Experience, made its successful return to Emirates Old Trafford – Lancashire County Cricket Club, Manchester on 27 September. The event, hosted by Thermo Fisher Scientific, showcased the latest in laboratory innovations available through Fisher Scientific.

Read the rest of entry »

Isansys announces that its advanced wireless patient monitoring platform granted key US patent

Isansys Lifecare, developer of the world’s most advanced real-time patient data collection and analysis platform, has been granted a US patent covering a key feature of its Lifetouch cardiac sensor

Read the rest of entry »

Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™Lung Liquid Biopsy Test

Draft Coverage Supports the Use of InVisionFirst-Lung for Aiding in the Management of Patients with Advanced Non-Small-Cell Lung Cancer . Inivata, a leader in liquid biopsy,  announced on 13 September that Palmetto GBA, a Medicare Administrative Contractor that  evaluates diagnostic technology through its laboratory technology assessment group, MolDx, has published a draft local coverage determination (LCD) for the InVisionFirst-Lung test.

Read the rest of entry »

Arecor secures £6m investment for the clinical development of its diabetes speciality pharma portfolio

On 10 September 2018 Arecor Ltd, the UK-based leader in developing superior biopharmaceuticals through the application of an innovative formulation technology platform, announced that it has secured £6.0 million of investment from new and existing investors for the clinical development of the Company’s speciality pharma portfolio of proprietary diabetes products.

Read the rest of entry »

Inivata Strengthens Senior Leadership Ahead of Next Stage of Company Growth

Inivata, a leader in liquid biopsy, today, 12 September, announces the strengthening of its senior leadership team with the appointment of Clive Morris, formerly Chief Medical Officer, as Chief Executive Officer, Stacy Chick as Chief Commercial Officer and Thomas Schlumpberger as VP Business Development.

Read the rest of entry »

Inivata to Present New Clinical Data on the Utility of the InVision® Liquid Biopsy Platform in Advanced Non-Small Cell Lung Cancer at the World Conference on Lung Cancer

Inivata, a leader in liquid biopsy announces that the company and its world-leading collaborators will showcase cutting-edge data in two mini oral presentations and six posters at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC) 23 - 26 September in Toronto. The details are as follows:

Read the rest of entry »

BioCity Group appoints leading life sciences expert to the Board to drive growth

BioCity, the Nottingham-headquartered life sciences incubation business, has appointed Stuart Henderson to the Board to help drive its growth and further strengthen its connections within the life sciences sector.

Read the rest of entry »

Evox raises €37m in Series B Round

Oxford, UK: Exosome drug delivery specialist Evox Therapeutics Ltd has closed a €37.1m (£35.5m) Series B financing round led by Redmile Group and significant contributions from GV (Google Ventures) and Cowen Healthcare Investments.

Read the rest of entry »

Ossianix and Novo Nordisk sign Research and Option Agreement on Blood Brain Barrier delivery technology for proteins in diabetes and other metabolic diseases

Philadelphia, PA, USA: Ossianix, Inc. today announced a research collaboration and option agreement with Novo Nordisk to deliver therapeutic molecules in diabetes and other metabolic diseases across the Blood Brain Barrier (BBB) to the brain.

Read the rest of entry »

Pages: Previous1234567...18NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.